Drug Shortage Report for MYLAN-LATANOPROST

Last updated on 2022-03-30 History
Report ID 156728
Drug Identification Number 02373041
Brand name GD-LATANOPROST
Common or Proper name Latanoprost
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) LATANOPROST
Strength(s) 50MCG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 1x2.5ml
ATC code S01EE
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-03-15
Estimated end date 2022-03-30
Actual end date 2022-03-29
Shortage status Resolved
Updated date 2022-03-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-03-30 English Compare
v9 2022-03-29 French Compare
v8 2022-03-29 English Compare
v7 2022-03-28 French Compare
v6 2022-03-28 English Compare
v5 2022-03-22 French Compare
v4 2022-03-22 English Compare
v3 2022-03-16 English Compare
v2 2022-03-15 French Compare
v1 2022-03-15 English Compare

Showing 1 to 10 of 10